Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC100287221 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GEO DataSets Profile neighbors
RBP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C11orf97 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TTC23 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PARD6B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPATA25 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UPB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USF3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM212A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM126A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MFSD2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IKZF4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LY6K - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on